← Open Payments lookup

EMEKA NNABUIFE: Open Payments

NPI 1497308399 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,141 in 94 payments from 17 companies in 2025. Trend: 2023 $141 · 2024 $2,053 · 2025 $3,141

Food & beverage: $3,141
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP12$774
ARS Pharmaceuticals Operations, Inc.17$405
GlaxoSmithKline, LLC.8$350
Takeda Pharmaceuticals U.S.A., Inc.9$297
Regeneron Healthcare Solutions, Inc.9$253
GENZYME CORPORATION2$181
Grifols USA, LLC9$150
CSL Behring7$149
Lilly USA, LLC2$124
Genentech USA, Inc.4$111

Products named: DUPIXENT, TEZSPIRE, NEFFY, FASENRA, NUCALA, Xembify, AIRSUPRA, Xolair.

Industry payments across TX — which companies pay providers there.